Hancock Whitney Corp Corcept Therapeutics Inc Transaction History

Hancock Whitney Corp

$2.88 Billion
Q1 2024

A detailed history of Hancock Whitney Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hancock Whitney Corp holds 27,497 shares of CORT stock, worth $867,805. This represents 0.02% of its overall portfolio holdings.

Number of Shares

27,497

Previous 11,930 130.49%

Holding current value

$867,805

Previous $387,000 78.81%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$21.1 - $27.46 $328,463 - $427,469	15,567 Added 130.49%	27,497 $692,000
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $446 - $591	-18 Reduced 0.15%	11,930 $387,000
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $9,491 - $14,601	-432 Reduced 3.49%	11,948 $325,000
Q2 2023 Nov 13, 2023	SELL	$21.44 - $25.15 $109,172 - $128,063	-5,092 Reduced 29.14%	12,380 $275,000
Q2 2023 Aug 10, 2023	SELL	$21.44 - $25.15 $109,172 - $128,063	-5,092 Reduced 29.14%	12,380 $275,000

Q1 2023 Nov 13, 2023	SELL	$19.2 - $24.47 $49,228 - $62,741	-2,564 Reduced 12.8%	17,472 $378,000
Q1 2023 May 16, 2023	SELL	$19.2 - $24.47 $49,228 - $62,741	-2,564 Reduced 12.8%	17,472 $378,000
Q4 2022 Nov 13, 2023	BUY	$19.95 - $29.96 $152,737 - $229,373	7,656 Added 61.84%	20,036 $406,000
Q4 2022 Feb 03, 2023	SELL	$19.95 - $29.96 $1,496 - $2,247	-75 Reduced 0.37%	20,036 $407,000
Q3 2022 Oct 26, 2022	SELL	$24.7 - $29.12 $11,534 - $13,599	-467 Reduced 2.27%	20,111 $516,000
Q2 2022 Aug 08, 2022	SELL	$17.33 - $25.3 $13,673 - $19,961	-789 Reduced 3.69%	20,578 $489,000
Q1 2022 May 12, 2022	SELL	$16.53 - $25.21 $72,169 - $110,066	-4,366 Reduced 16.97%	21,367 $481,000
Q4 2021 Jan 25, 2022	SELL	$17.1 - $23.34 $3,471 - $4,738	-203 Reduced 0.78%	25,733 $510,000
Q3 2021 Nov 04, 2021	SELL	$19.68 - $22.53 $1,830 - $2,095	-93 Reduced 0.36%	25,936 $510,000
Q2 2021 Aug 09, 2021	SELL	$19.97 - $24.43 $154,867 - $189,454	-7,755 Reduced 22.95%	26,029 $573,000
Q1 2021 May 14, 2021	SELL	$23.49 - $30.56 $11,369 - $14,791	-484 Reduced 1.41%	33,784 $803,000
Q4 2020 Feb 09, 2021	SELL	$16.78 - $27.3 $3,305 - $5,378	-197 Reduced 0.57%	34,268 $897,000
Q3 2020 Nov 05, 2020	SELL	$12.46 - $19.98 $2,130 - $3,416	-171 Reduced 0.49%	34,465 $599,000
Q2 2020 Jul 30, 2020	SELL	$11.0 - $18.26 $46,651 - $77,440	-4,241 Reduced 10.91%	34,636 $583,000
Q1 2020 May 08, 2020	BUY	$10.11 - $14.04 $112,392 - $156,082	11,117 Added 40.05%	38,877 $462,000
Q4 2019 Feb 06, 2020	SELL	$12.06 - $16.96 $178,005 - $250,329	-14,760 Reduced 34.71%	27,760 $336,000
Q3 2019 Oct 29, 2019	SELL	$10.41 - $14.66 $61,439 - $86,523	-5,902 Reduced 12.19%	42,520 $601,000
Q2 2019 Aug 29, 2019	BUY	$9.78 - $12.76 $473,567 - $617,864	48,422 New	48,422 $540,000

Others Institutions Holding CORT

# of Institutions

315

Shares Held

93.8M

Call Options Held

2.02M

Put Options Held

3.24M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.38B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account

Hancock Whitney Corp Corcept Therapeutics Inc Transaction History